← Back to patent-cliff list
Ibogaine
Tier C — Watch / tradeIbogaine
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：DAT, MOR1, KOR1, SERT
Indications (approved)：Alcohol abuse, Post-traumatic stress disorder, Traumatic brain injury, 脑损伤, Mild cognitive impairment
Regional status
US
Discontinued
2025-09-01
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ibogaine?
Approved indications include: Alcohol abuse, Post-traumatic stress disorder, Traumatic brain injury, 脑损伤, Mild cognitive impairment.
When does the Ibogaine patent expire?
No public expiry year is available for Ibogaine yet; this page updates once verified.
How do I get a quote for Ibogaine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-03